HM-30181 mesylate monohydrate
CAS No. 2097125-58-9
HM-30181 mesylate monohydrate( —— )
Catalog No. M23945 CAS No. 2097125-58-9
HM-30181 mesylate monohydrate is an oral P-glycoprotein (P-gp) inhibitor, used to enhance the oral bioavailability of P-gp substrate drugs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 81 | In Stock |
|
5MG | 115 | In Stock |
|
10MG | 185 | In Stock |
|
25MG | 309 | In Stock |
|
50MG | 443 | In Stock |
|
100MG | 644 | In Stock |
|
200MG | 835 | In Stock |
|
500MG | 1251 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHM-30181 mesylate monohydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionHM-30181 mesylate monohydrate is an oral P-glycoprotein (P-gp) inhibitor, used to enhance the oral bioavailability of P-gp substrate drugs.
-
DescriptionHM-30181 mesylate monohydrate is an oral P-glycoprotein (P-gp) inhibitor, used to enhance the oral bioavailability of P-gp substrate drugs.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorP-gp?(P-glycoprotein)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2097125-58-9
-
Formula Weight784.84
-
Molecular FormulaC39H40N6O10S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO.COc1cc2CCN(CCc3ccc(cc3)n4nnc(n4)c5cc(OC)c(OC)cc5NC(=O)C6=CC(=O)c7ccccc7O6)Cc2cc1OC.CS(=O)(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cha YJ, Lee H, Gu N, Kim TE, Lim KS, Yoon SH, Chung JY, Jang IJ, Shin SG, Yu KS, Cho JY. Sustained Increase in the Oral Bioavailability of Loperamide after a Single Oral Dose of HM30181, a P-glycoprotein Inhibitor, in Healthy Male Participants. Basic Clin Pharmacol Toxicol. 2013 Jul 6.
molnova catalog
related products
-
Etifoxine hydrochlor...
Etifoxine is an anxiolytic and anticonvulsant drug.?Unlike benzodiazepines, etifoxine appears to produce its anxiolytic effects by binding to β2 and β3 subunits of the GABAA receptor complex, and so is acting at a different target site to benzodiazepines, although the physiological effect that is produced is similar to that of benzodiazepines.
-
KHK-IN-1
KHK-IN-1 is a reversible and ATP-competitive inhibitor of ketohexokinase (KHK) with IC50 of 12 nM. In the ATP-binding region of KHK, KHK-IN-1 interacts with Asp-27B.
-
9-Ethylguanine
9-Ethylguanine is a model nucleobase commonly used in the studies of DNA interactions with organometallic complexes.